Cleveland Biolabs Inc. to Host Press Conference on Radiation Countermeasure Developments for National Security and Oncologic Safety

BUFFALO, N.Y., Feb. 22, 2010 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI), an innovator of drugs for treatment of cancer and protection of normal tissues from exposure to radiation, is holding a press conference to discuss business and clinical advances.